“…Among six different tau isoforms expressed in humans, the longest one (2N4R) contains 441 residues . The residual sequence of 2N4R (Figure ) can be divided into several regions, where the N-terminus (with two inserts, N1 and N2) is followed by the proline-rich region (P1 and P2), the microtubule binding region composed of four pseudo-repeats (R1–R4), and a shorter C-terminal tail. ,, Tau is a highly soluble protein with a small number of hydrophobic residues in the sequence, and the molecule has a tendency to fluctuate among different conformations without having a specific stable tertiary structure, which makes tau an intrinsically disordered protein (IDP). ,, In order to aggregate into fibrils, tau usually requires additional external factors or post-translational modifications that convert it to a pro-aggregant. − Charged anionic cofactors, such as sulfated glycosaminoglycans, nucleic acids, and fatty acids, have been found to induce aggregation of tau, presumably by assisting in overcoming the nucleation barrier on the aggregation pathway. − For example, the colocalization of NFTs and heparan sulfate, a highly acidic glycosaminoglycan (GAG) modified by sulfate, in the isolated brain samples of AD patients suggests an important role of this polyanionic cofactor in tau fibrillation in vivo . It is suggested that the polyanionic molecule can interact electrostatically with positively charged residues in the repeat regions of tau, thereby reducing electrostatic repulsions of the repeat regions, alleviating tau–tau interaction, and stabilizing the β-conformation. ,, Given the importance of electrostatic interactions in the interactions of anionic polymers and tau, as well as polyanion-mediated self-association and aggregation of tau, one would hypothesize that polyelectrolytes containing positive charges may play an opposite role and interfere with tau aggregation, although few such studies have been reported so far.…”